Cutting Edge: B Cell–Intrinsic T-bet Expression Is Required To Control Chronic Viral Infection
Author(s) -
Burton E. Barnett,
Ryan P. Staupe,
Pamela M. Odorizzi,
Olesya Palko,
Vesselin T. Tomov,
Alison E. Mahan,
Bronwyn M. Gunn,
Diana Chen,
Michael Paley,
Galit Alter,
Steven L. Reiner,
Georg M. Lauer,
John R. Teijaro,
E. John Wherry
Publication year - 2016
Publication title -
the journal of immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.737
H-Index - 372
eISSN - 1550-6606
pISSN - 0022-1767
DOI - 10.4049/jimmunol.1500368
Subject(s) - immune system , biology , b cell , virus , t cell , cell , immunology , virology , antibody , genetics
The role of Ab and B cells in preventing infection is established. In contrast, the role of B cell responses in containing chronic infections remains poorly understood. IgG2a (IgG1 in humans) can prevent acute infections, and T-bet promotes IgG2a isotype switching. However, whether IgG2a and B cell-expressed T-bet influence the host-pathogen balance during persisting infections is unclear. We demonstrate that B cell-specific loss of T-bet prevents control of persisting viral infection. T-bet in B cells controlled IgG2a production, as well as mucosal localization, proliferation, glycosylation, and a broad transcriptional program. T-bet controlled a broad antiviral program in addition to IgG2a because T-bet in B cells was important, even in the presence of virus-specific IgG2a. Our data support a model in which T-bet is a universal controller of antiviral immunity across multiple immune lineages.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom